Buprenorphine for office-based practice: consensus conference overview.

Buprenorphine for office-based practice: consensus conference overview.

Item
http://www.wikidata.org/entity/Q35809677
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.Buprenorphine retention in primary care.On blending practice and research: the search for commonalities in substance abuse treatment.Pharmacogenetic treatments for drug addiction: alcohol and opiates.Advanced urine toxicology testing.False-positive interferences of common urine drug screen immunoassays: a review.Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program.Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting.
P2860

Buprenorphine for office-based practice: consensus conference overview.

Item
http://www.wikidata.org/entity/Q35809677
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Buprenorphine for office-based practice: consensus conference overview.
@ast
Buprenorphine for office-based practice: consensus conference overview.
@en
type
label
Buprenorphine for office-based practice: consensus conference overview.
@ast
Buprenorphine for office-based practice: consensus conference overview.
@en
prefLabel
Buprenorphine for office-based practice: consensus conference overview.
@ast
Buprenorphine for office-based practice: consensus conference overview.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P698
P356
P1433
P1476
Buprenorphine for office-based practice: consensus conference overview.
@en
P2093
U.S. National Buprenorphine Implementation Program
P304
P31
P356
P478
P50
P577
P698